April 04, 2026 10:29 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
AAP drops Raghav Chadha from key parliamentary role, sparks buzz over internal rift | Amit Shah to camp in West Bengal for 15 days during Assembly polls; predicts Mamata’s defeat in state and Bhabanipur | 'BJP plotting President’s Rule, don’t fall in the trap': Mamata Banerjee on Malda unrest, urges peace | 'Most polarised state': CJI Kant raps Bengal govt over 9-hour hostage of judicial officers | Bengal SIR protest: Judge pleads for help amid mob attack after 9-hour hostage ordeal | Bengal SIR progress: 47 lakh of 60 lakh adjudicated cases disposed of, Supreme Court informed | Amit Shah to join Suvendu Adhikari on Bhabanipur nomination day; BJP plans mega roadshow | Fuel prices rise: Premium petrol, diesel hiked amid oil price surge | Commercial LPG up Rs 195.50 as global oil prices rise; domestic rates unchanged | Layoff alert: Oracle cuts 30,000 jobs globally, 12,000 hit in India
Imran Khan

Pakistani Prime Minister Imran Khan oks COVID-19 vaccine procurement from 2 firms - Reports

| @indiablooms | Nov 17, 2020, at 11:10 pm

Moscow/Sputnik: Pakistani Prime Minister Imran Khan has greenlighted advance booking of COVID-19 vaccines with two unnamed candidates in the running, media reported Tuesday.

According to news outlet Geo Pakistan, Parliamentary Secretary for Health Nausheen Hamid said that 10 million Pakistani nationals will be vaccinated during the first phase, with the priority given to frontline workers and people aged over 65 years.

No details of the origin of the shortlisted vaccines were given, although Pakistan’s coronavirus taskforce last week indicated that authorities will consider Chinese-made vaccines over US-made ones due to the different requirements in transportation and storage, Geo Pakistan reported.

The vaccines produced by US firms Pfizer and Moderna must be stored in temperatures of -30 to -90 degrees Fahrenheit, requiring what is called a cold chain, a major challenge for vaccine distribution in developing nations.

Chinese-made vaccines, which are currently undergoing third phase trials in Pakistan, remain effective at room temperatures, Geo reported citing the taskforce.

Fewer than a dozen vaccine candidates are showing efficacy in the third phase trials, mainly from the US, Russia and China, while many other COVID-19 vaccine developments are still underway. Many nations have begun scrambling to secure pledges of vaccine procurement before they are mass-produced.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.